Clinical trial
Post-Market Surveillance Study of the TM Ardis Interbody Fusion System
NCT02429908 · Zimmer Biomet, Industry · Completed
Key facts
| NCT number | NCT02429908 |
|---|---|
| Title | Post-Market Surveillance Study of the TM Ardis Interbody Fusion System |
| Official title | A Prospective, Multi-Center, Post-Market Surveillance Study to Assess the Clinical Efficacy and Fusion Rates of the Zimmer TM Ardis Interbody Fusion System |
| Lead sponsor | Zimmer Biomet, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Degenerative Disc Disease |
| Intervention type | Device |
| Interventions | TM-Ardis Interbody |
| Enrollment | 80 |
| Start date | Mar 1, 2014 |
| Primary completion | Sep 14, 2018 |
| Completion | Sep 14, 2018 |
| First posted | Apr 29, 2015 |
| Last update posted | Mar 15, 2019 |
| Countries | Belgium, Canada, France, Germany, Spain, Sweden |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: